Oct 2026· SN Comprehensive Clinical Medicine· Vol 8· 0 citations· 29 references
TL;DR
These registry-based estimates, which are broadly comparable with GBD modelled estimates, provide a baseline for monitoring CRC burden and would strengthen future estimates and evaluation of the national screening programme.
Abstract
Colorectal cancer (CRC) incidence is rising in Brunei Darussalam, but its overall health burden has not been quantified using Disability-Adjusted Life Years (DALYs). We estimated the national CRC DALY burden for 2002–2020 by sex, disease stage, and age at onset, and assessed the sensitivity of estimates to key modelling assumptions. In this retrospective, population-based study of 1,373 CRC patients diagnosed 2002–2020 and followed to 31 December 2021, DALYs were calculated with an incidence-based approach as Years of Life Lost (YLL) plus Years Lived with Disability (YLD), using a phase-based model adapted from the Global Burden of Disease (GBD) colorectal cancer model. Rates were age-standardized to the WHO World Standard Population using citizen and permanent resident person-years as denominators, and stratified by sex, stage, age group, and onset age. Because cause of death was unavailable, YLL was restricted to CRC-attributable deaths estimated with an excess-mortality (relative survival) approach. Temporal trends were re-estimated with fixed 1- and 5-year follow-up windows and a calendar-period approach, and sensitivity analyses examined death attribution, phase durations, and disability weights. An estimated 490.7 of 604 recorded deaths were attributable to CRC. CRC caused 15,244.3 DALYs (YLL 94.5%, YLD 5.5%), an age-standardized rate of 309.2 per 100,000 person-years (males 349.5; females 269.6). DALYs per case rose from 4.3 at localised to 21.4 at distant stage. Early-onset cases (< 50 years, 21.5% of the cohort) accrued 18.9 DALYs per case versus 9.0 for common-onset cases, reflecting more years of life lost per CRC death (46.0 versus 24.1) rather than higher case-fatality (41.0% versus 44.8%). With comparable follow-up there was no evidence of a decline after 2015; the apparent decline reflected shorter follow-up of recently diagnosed cases. The age-standardized 1-year DALY rate rose by 6.2% per year (95% CI 2.7 to 9.8) among cases diagnosed 2002–2018, but not among cases diagnosed from 2008 onwards (0.7% per year, 95% CI − 3.3 to 4.9), suggesting that the earlier rise may reflect incomplete death ascertainment in 2002–2007. Registry estimates for 2019 lay within the uncertainty interval of GBD 2023 estimates for Brunei. Attributing all recorded deaths to CRC increased total DALYs by 13.0%; phase-duration and disability-weight assumptions changed totals by − 2.2% to + 6.6%. CRC imposes a substantial, mortality-dominated burden in Brunei Darussalam, with no evidence of a decline over the study period. The higher burden per early-onset case reflects years of life lost at younger ages rather than higher case-fatality. These registry-based estimates, which are broadly comparable with GBD modelled estimates, provide a baseline for monitoring CRC burden; cause-of-death data and complete death linkage would strengthen future estimates and evaluation of the national screening programme.
The concurrent increase in incidence and, particularly, YLDs suggests an epidemiological shift toward a greater nonfatal burden among Iranian adolescents and supports the need for comprehensive survivorship care and stronger cancer registration and surveillance systems to address emerging challenges in adolescent oncol...
H. Azarbakhsh, Andishe Hamedi, Sanaz Amiri et al.· Health Science Reports· 0 citations
BACKGROUND
Gastric cancer (GC) is a substantial global health burden, with early-onset gastric cancer (EOGC) posing distinct diagnostic and management challenges in adolescents and young adults. This study evaluated the global burden, temporal trends, and associated factors of EOGC.
METHODS
Using Global Burden of Dis...
Xin-Ye Cui, Yu-Zhuo Chen, Ze-Yu Jiao et al.· Journal of Clinical Gastroen...· 0 citations
Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.
Ke Zhang, Zhi-Fei Chen· Digestive Diseases· 0 citations
Background Early-onset breast cancer (EOBC) affects women aged 15–44 years during reproductive and economically active life stages. We quantified global, regional, and national EOBC burden from 1990 to 2021, including temporal inflection points, modifiable risks, and health inequalities. Methods Using Global Burden of...
Xing-Tong Zhou, Xiao-Ying Zhong, Mo-Han Liu et al.· International Journal of Wom...· 0 citations
ObjectiveThyroid cancer incidence has risen steadily, and elevated body mass index (BMI) is a modifiable risk factor for it. We assessed the disease burden of high BMI-attributable thyroid cancer across the BRICS countries (Brazil, Russia, India, China, and South Africa), which have undergone rapid lifestyle transition...
Yu Qian, Song Chen, Nan-Peng Wang et al.· Science in progress· 0 citations
Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality worldwide, and analyzing its most recent disease trends is essential for effective prevention and control strategies. Data on the global burden of EC were obtained from the 2021 Global Burden of Disease study, including prevalence, incidence,...
Yi-Fan Li, Guo-Peng Jiang, Xia Liu et al.· Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.